What to Consider When Purchasing Mammography Equipment for Your Facility

10/16/20

When digital breast tomosynthesis was approved for mammography by the Food and Drug Administration in 2011, the 3-dimensional technology brought increased insight into women’s health care, but it did not replace 2D imaging. Instead the two systems complemented each other. Today, however, new technology is poised to change that.

More

A Tale of Two Pandemics

10/14/20

The COVID-19 pandemic, rampant since March, has interrupted life in ways not seen in our country in over a century. With vaccines in development, we just may have a light at the end of the tunnel. The spread of misinformation, the other pandemic, has serious implications for healthcare and no cure in sight. 

More

It’s Time to Re-evaluate Insurance Coverage for Events With a Deadly Weapon

09/29/20

In settings where employees are entirely focused on providing care, ensuring that patients, visitors and employees alike are safe is of paramount importance. Unfortunately, incidents of violence can occur, and health care providers need to consider how to mitigate and manage these risks.

More

Health Care Disruption and the Dog that Didn’t Bark

09/22/20

In the year before the global pandemic, Vizient research was calling attention to the vulnerability of the traditional health system business model, highly dependent on enormous profitability on a very small subset of patients to offset unfavorable economics on the bulk of provider volume.

 

More

Emergency Medicine Now and in the Future

09/08/20

Have you ever wondered how hospital emergency departments (EDs) got their name when a large majority of the people who visit them are not experiencing an emergency? Should they be called something else, or should they finally serve only those patients with emergencies? These are interesting thoughts and questions; the answers are not easily surmised.

More

The Perils of a Fire Sale in the Wake of the Pandemic

08/26/20

In his latest blog post, Vizient Research Institute executive director Tom Robertson urges caution when contemplating the merits of additional provider consolidation stemming from the economic impacts of the global crisis. The mere prospect of all payer rate regulation somewhere down the road — hardly a certainty but extraordinarily disruptive were it to occur — makes applying traditional revenue and pricing assumptions to a new normal future increasingly tenuous.

More

When Perception and Reality Are at Odds: 5 Ways to Get Clinician Buy-in for New Products

08/13/20

From cost-saving initiatives and quality enhancements to the introduction of new technology that will drive procedural efficiencies, there are many reasons for supply chain leaders to introduce new products to clinicians. But how new products are presented can make or break clinician acceptance.

More

Refocusing on Accreditation Compliance After the Pandemic

08/10/20

Here are five key strategies to help refocus your team during this pandemic and resume proactive, continuous accreditation compliance to help ensure your organization is always “survey ready.”

More

Transitioning from Value Analysis to Clinical-Supply Integration: It’s All About the Process

08/05/20

Clinical-supply integration (CSI) has become a recognizable concept for many health care organizations as they continue to focus on performance improvement. But many are unsure how to operationalize a CSI model that fits their organization. 

More

Getting from Good to Great: Using Data to Move From Traditional Product Standardization to Clinical-Supply Integration

08/05/20

John D. Rockefeller once said, “Don’t be afraid to give up the good to go for the great.” It’s hard to argue with Rockefeller’s successful approach to business. To apply his philosophy in supply chain, we need to rethink our approach to product decision-making.

More